Indication

Pulmonary thromboembolism

Pulmonary thromboembolism is a life-threatening form of venous thromboembolism characterized by the occlusion of one or more pulmonary arterial branches by a thrombus, which most frequently originates from the deep veins of the lower extremities or pelvis. Read more about Pulmonary thromboembolism

114 drugs 64 manufacturers

Advertisement

Drugs that treat it

Common Pulmonary thromboembolism therapies.

Showing 100–108 of 114 drugs

WARFARIN SODIUM

ORAL ANTICOAGULANTS·MYOCARDIAL REINFARCTION PREVENTION·+12
TARO/SUN PHARMA

RIVAROXABAN

ORAL ANTICOAGULANTS·MYOCARDIAL INFARCTION PREVENTION·+10
SCIEGEN PHARMAC

RIVAROXABAN

ORAL ANTICOAGULANTS·MYOCARDIAL INFARCTION PREVENTION·+10
EXELAN PHARMACE

RIVAROXABAN

ORAL ANTICOAGULANTS·MYOCARDIAL INFARCTION PREVENTION·+10
FLORIDA PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Pulmonary thromboembolism preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pulmonary thromboembolism.

Pulmonary thromboembolism is a life-threatening form of venous thromboembolism characterized by the occlusion of one or more pulmonary arterial branches by a thrombus, which most frequently originates from the deep veins of the lower extremities or pelvis.

This mechanical obstruction abruptly increases pulmonary vascular resistance and right ventricular afterload, impairing gas exchange and potentially progressing to acute right ventricular strain or failure.

Affected individuals may present with a spectrum of manifestations ranging from mild dyspnea, tachypnea, and pleuritic chest pain to severe hypoxemia, hemoptysis, syncope, and hemodynamic instability.

Personalize your experience

Follow Pulmonary thromboembolism and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it